OCT 17, 2016 2:03 PM PDT

Scripps Florida Scientists Uncover New Facets of Zika-Related Birth Defects to Help Develop Treatment

Image Credit: CDC

JUPITER, FL – October 17, 2016 – In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute (TSRI) have elucidated how the virus attacks the brains of newborns, information that could accelerate the development of treatments.

The study, led by TSRI Associate Professors Hyeryun Choe and Damon Page, was published recently in the journal Nature Scientific Reports.

In the new study, the scientists observed the virus’s effects in animal models at two different points—during early postnatal development, when the brain is growing rapidly, and at weaning, when the brain has largely reached adult size.

“In early postnatal Zika-infected models some brain areas and cell types showed particularly large increases in apoptosis [programmed cell death] that we did not observe in older animals,” Choe said.

The findings expand the current knowledge of cell types vulnerable to the effects of Zika infection to include not only neuron progenitor cells, but also post-mitotic neurons that have finished dividing but are still are undergoing rapid increases in cell size. These results are consistent with the theory that periods of rapid brain growth are especially susceptible to the damaging neurodevelopmental effects of Zika infection.

“An interesting aspect of the study is the comparison of the two time points,” Page noted. “There is neural cell death at both times, but it’s much greater when the brain is growing rapidly. We can take advantage of this strong effect to test potential treatments and to understand whether some genetic backgrounds may confer enhanced susceptibility or resilience to Zika-induced microcephaly.”

ika virus was first isolated in rhesus macaque monkeys in Uganda in 1947. Transmitted by mosquito, it is related to several other human pathogens, including West Nile virus, dengue, Japanese encephalitis virus and yellow fever. As widely reported, the 2015 Zika epidemic in Brazil coincided with a dramatic increase in cases of microcephalic newborns.

“Our findings establish a valuable model to investigate the mechanisms that underlie the horrific birth defects associated with Zika infection,” said TSRI Graduate Student Wen-Chin Huang, the first author of the study.

The team is continuing to build on this study to better understand and combat the virus.

In addition to Choe, Page and Huang, other authors of the study, “Zika Virus Infection During the Period Of Maximal Brain Growth Causes Microcephaly and Corticospinal Neuron Apoptosis in Wild Type Mice,” include Rachy Abraham and Byoung-Shik Shim of TSRI.

The study was supported by the National Institutes of Health (grant R01 AI110692) and by Ms. Nancy Lurie Marks.

This article was originally published on Scripps.edu.
About the Author
  • The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 2,700 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists-including two Nobel laureates-work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.
You May Also Like
MAR 13, 2020
Immunology
MAR 13, 2020
Malaria drug treats lupus and prevents diabetes
A drug commonly used to treat certain types of malaria has been found to have some surprising synergistic effects: havin ...
MAR 19, 2020
Drug Discovery & Development
MAR 19, 2020
Could a 1949 Malaria Drug Treat COVID-19?
In the race to halt the current coronavirus pandemic, scientists, health experts and even Elon Musk are considering chlo ...
MAR 29, 2020
Cell & Molecular Biology
MAR 29, 2020
Learning More About Boosting Immunity in Older Adults
Older adults are more susceptible to infections and don't generate a robust immune response after a vaccination.
APR 02, 2020
Immunology
APR 02, 2020
Transforming T Cells into Powerful Memory Cells That Target Cancer
New cancer treatments are now based on harnessing the power of the human body’s own immune cells to get the job do ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
MAY 19, 2020
Drug Discovery & Development
MAY 19, 2020
COVID-19 Vaccine On Track for Late 2020
Moderna, a biotechnology company based in Massachusetts, has released information on its vaccine against COVID-19 from i ...
Loading Comments...